Page last updated: 2024-11-11

ambruticin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

ambruticin: cyclopropyl-polyene-pyran acid from Polyangium cellulosum var. fulvum; RN given refers to parent cpd; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

ambruticin S: antifungal from myxobacterium Polyangium cellulosum; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID6436037
MeSH IDM0063892
PubMed CID6918547
CHEMBL ID522783
SCHEMBL ID397001
MeSH IDM0063892

Synonyms (33)

Synonym
ambruticin
ambruticin s
w-7783 ,
w7783 ,
ambruticin (usan/inn)
D02883
smp-78 acid s
w 7783
2h-pyran-2-acetic acid, 6-(2-(2-(5-(6-ethyl-3,6-dihydro-5-methyl-2h-pyran-2-yl)-3-methyl-1,4-hexadienyl)-3-methylcyclopropyl)ethenyl)tetrahydro-4,5-dihydroxy-
antibiotic acid s
ambruticinum [inn-latin]
ambruticine [inn-french]
ambruticin [usan:inn]
ambruticino [inn-spanish]
6-(2-(2-(5-(6-ethyl-3,6-dihydro-5-methyl-2h-pyran-2-yl)-3-methyl-1,4-hexadienyl)-3-methylcyclopropyl)vinyl)tetrahydro-4,5-dihydroxy-2h-pyran-2-acetic acid
nsc-328415
CHEMBL522783
2-[(2s,4s,5r,6s)-6-[(e)-2-[(1s,2s,3r)-2-[(1e,3r,4e)-5-[(2r,6r)-6-ethyl-5-methyl-3,6-dihydro-2h-pyran-2-yl]-3-methylhexa-1,4-dienyl]-3-methylcyclopropyl]ethenyl]-4,5-dihydroxyoxan-2-yl]acetic acid
nsc 328415
x794618736 ,
ambruticine
unii-x794618736
ambruticinum
ambruticino
6-[2-[2-[5-(6-ethyl-3,6-dihydro-5-methyl-2h-pyran-2-yl)-3-methyl-1,4-hexadienyl]-3-methylcyclopropyl]vinyl]tetrahydro-4,5-dihydroxy-2h-pyran-2-acetic acid
ambruticin [usan]
ambruticin [inn]
(+)-ambruticin s
(+)-ambruticin
SCHEMBL397001
Q27293636
DTXSID701024202
AKOS040750394

Research Excerpts

Overview

Ambruticins are a family of polyketides.

ExcerptReferenceRelevance
"Ambruticins are a family of polyketides. "( Efficacy of ambruticin analogs in a murine model of invasive pulmonary aspergillosis.
Chiang, LY; Ejzykowicz, DE; Filler, SG; Katz, L; Tian, ZQ, 2006
)
2.16
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (11)

Assay IDTitleYearJournalArticle
AID1134945Antifungal activity against Microsporum fulvum assessed as growth inhibition by standard broth dilution method1979Journal of medicinal chemistry, Sep, Volume: 22, Issue:9
Antifungal agents. 4. Chemical modification of antibiotics from Polyangium cellulosum var. fulvum. Ester and amide analogues of ambruticin.
AID1134946Antifungal activity against Streptococcus pyogenes assessed as growth inhibition by standard broth dilution method1979Journal of medicinal chemistry, Sep, Volume: 22, Issue:9
Antifungal agents. 4. Chemical modification of antibiotics from Polyangium cellulosum var. fulvum. Ester and amide analogues of ambruticin.
AID1134944Antifungal activity against Histoplasma capsulatum assessed as growth inhibition by standard broth dilution method1979Journal of medicinal chemistry, Sep, Volume: 22, Issue:9
Antifungal agents. 4. Chemical modification of antibiotics from Polyangium cellulosum var. fulvum. Ester and amide analogues of ambruticin.
AID417426Elevation of Hog1 phosphorylation Saccharomyces cerevisiae ATCC 201388 carrying pYES2-HIK1 at 25 ppm after 4 hrs in SD/-Ura medium by Western blot analysis2007Antimicrobial agents and chemotherapy, Oct, Volume: 51, Issue:10
The antifungal polyketide ambruticin targets the HOG pathway.
AID1134909Antifungal activity against Candida albicans by standard broth dilution technique1979Journal of medicinal chemistry, Sep, Volume: 22, Issue:9
Antifungal agents. 5. Chemical modification of antibiotics from Polyangium cellulosum var. fulvum. Alcohol, ketone, aldehyde, and oxime analogues of ambruticin.
AID1134910Antifungal activity against Histoplasma capsulatum assessed as growth inhibition after 3 days by standard broth dilution technique1979Journal of medicinal chemistry, Sep, Volume: 22, Issue:9
Antifungal agents. 5. Chemical modification of antibiotics from Polyangium cellulosum var. fulvum. Alcohol, ketone, aldehyde, and oxime analogues of ambruticin.
AID1134908Antibacterial activity against Streptococcus pyogenes by standard broth dilution technique1979Journal of medicinal chemistry, Sep, Volume: 22, Issue:9
Antifungal agents. 5. Chemical modification of antibiotics from Polyangium cellulosum var. fulvum. Alcohol, ketone, aldehyde, and oxime analogues of ambruticin.
AID1134947Antifungal activity against Candida albicans assessed as growth inhibition by standard broth dilution method1979Journal of medicinal chemistry, Sep, Volume: 22, Issue:9
Antifungal agents. 4. Chemical modification of antibiotics from Polyangium cellulosum var. fulvum. Ester and amide analogues of ambruticin.
AID417427Elevation of Hog1 phosphorylation Saccharomyces cerevisiae ATCC 201388 carrying pYES2 at 25 ppm after 4 hrs in SD/-Ura medium by Western blot analysis2007Antimicrobial agents and chemotherapy, Oct, Volume: 51, Issue:10
The antifungal polyketide ambruticin targets the HOG pathway.
AID1134911Antifungal activity against Microsporum fulvum assessed as growth inhibition after 3 days by standard broth dilution technique1979Journal of medicinal chemistry, Sep, Volume: 22, Issue:9
Antifungal agents. 5. Chemical modification of antibiotics from Polyangium cellulosum var. fulvum. Alcohol, ketone, aldehyde, and oxime analogues of ambruticin.
AID417300Elevation of Hog1 phosphorylation Saccharomyces cerevisiae ATCC 201388 carrying deltahog1 gene at 25 ppm after 4 hrs in SD/-Ura medium by Western blot analysis2007Antimicrobial agents and chemotherapy, Oct, Volume: 51, Issue:10
The antifungal polyketide ambruticin targets the HOG pathway.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (30)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (16.67)18.7374
1990's3 (10.00)18.2507
2000's14 (46.67)29.6817
2010's5 (16.67)24.3611
2020's3 (10.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 21.97

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index21.97 (24.57)
Research Supply Index3.43 (2.92)
Research Growth Index4.82 (4.65)
Search Engine Demand Index21.17 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (21.97)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Trials0 (0.00%)5.53%
Reviews2 (6.67%)6.00%
Reviews1 (20.00%)6.00%
Case Studies0 (0.00%)4.05%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Observational0 (0.00%)0.25%
Other28 (93.33%)84.16%
Other4 (80.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]